戻る Agenda
China - Update on the Regulatory Environment
Session Chair(s)
Joseph Scheeren, PHARMD
Founder
Scheeren HealthCare LLC, United States
• Latest Changes in NMPA • Update on the (Clinical) Development Environment /Regulations/Approvals in China • Update on the GCP/GMP Environment in China and its Changes
Speaker(s)
The Latest Progress of the Drug Regulatory Environment in China
Jianqing Chang, DrMed
Tigermed Consulting Ltd., China
Vice President, Drug Regulatory Policy
China Speed: An Overview of Fast Evolving Biopharma Innovation Ecosystem in China
Walter Beck, DVM
Bayer AG, Germany
Panelist
Lingshi Tan, PHD
Caidya, United States
Chief Executive Officer